Vectura Group

VEC

GB00BKM2MW97

Delayed London S.E. Other stock markets 09:05:22 18/10/2021 pm IST			5-day change	1st Jan Change
164.8 ^GBX	-.--%		-.--%	-.--%

16/04	Mundipharma and Vectura Announce Plans to Reformulate Fluticasone Propionate/Formoterol Fumarate	CI
2021	EnBiotix, Inc. announced that it has received $11 million in funding from Vectura Group plc, Cystic Fibrosis Foundation	CI

Vectura Group plc Appoints Anne Whitaker as Non-Executive Director

June 01, 2018 at 04:04 pm IST

Vectura Group plc confirmed the appointment of Anne Whitaker as a Non-Executive Director of the company with effect from 1 June 2018.

Latest news about Vectura Group

Mundipharma and Vectura Announce Plans to Reformulate Fluticasone Propionate/Formoterol Fumarate	16/04	CI
EnBiotix, Inc. announced that it has received $11 million in funding from Vectura Group plc, Cystic Fibrosis Foundation	29/21/29	CI
Philip Morris CEO does not need M&A to hit smoke free goals	03/21/03	RE
Philip Morris International : Raises Lobbying Concerns Over $1.4 Billion Vectura Deal	25/21/25	MT
PMI Global Services, Inc Completes the Acquisition of Vectura Group plc	19/21/19	CI
Vectura Group plc's Equity Buyback announced on September 10, 2019, has expired.	19/21/19	CI
PMI Global Services, Inc. completed the acquisition of Vectura Group plc from AXA Investment Managers S.A., Legal & General Investment Management Limited, The Vanguard Group, Inc. and others.	19/21/19	CI
Vectura Group plc(LSE:VEC) dropped from S&P Global BMI Index	08/21/08	CI
Philip Morris International : Extends Offer Period For Vectura Takeover	01/21/01	MT
Morrisons takeover battle will go to UK auction on Oct. 2	29/21/29	RE
Vectura Group plc(LSE:VEC) dropped from FTSE 250 Index	21/21/21	CI
Vectura Group plc(LSE:VEC) dropped from FTSE 250 (Ex Investment Companies) Index	21/21/21	CI
Vectura Group plc(LSE:VEC) dropped from FTSE 350 (Ex Investment Companies) Index	21/21/21	CI
Vectura Group plc(LSE:VEC) dropped from FTSE 350 Index	21/21/21	CI
Vectura Group plc(LSE:VEC) dropped from FTSE All-Share Index	21/21/21	CI
Vectura Group plc(LSE:VEC) dropped from FTSE techMARK All-Share Index	21/21/21	CI
Philip Morris International : to Delist Britain's Vectura on Oct. 19	20/21/20	MT
Vectura : Pharmaceutical Conference Bans Vectura After Takeover By Philip Morris	20/21/20	MT
Augean : Buyout battle for waste management firm Augean headed to auction - regulator	16/21/16	RE
Today on Wall Street: US economy shows resilience, while China falters	16/21/16
Philip Morris seals deal for UK's Vectura despite health group concerns	16/21/16	RE
FTSE Rises, Ashtead Gains After 1Q Profit Boost, Guidance Increase	16/21/16	DJ
Philip Morris Confirms Majority of Vectura Shareholders Agree to Takeover	16/21/16	CI
Philip Morris International : Secures Vectura Takeover with 75% support	16/21/16	MT
BOE Expected to Leave Policy Unchanged Next Week	16/21/16	DJ

Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) - LABA-LAMA; Seebri Breezhaler (EU and RoW) - LAMA; AirFluSal Forspiro (EU and RoW) - ICS-LABA; ADVATE (Global) - Antihaemophilic Factor (Recombinant); Adept (Global) - Icodextrin; Anoro Ellipta (Global) - LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) - ICS-LABA, and Incruse Ellipta (Global) - LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.

Sector

More about the company

Vectura Group

Equities

VEC

GB00BKM2MW97

Vectura Group plc Appoints Anne Whitaker as Non-Executive Director

Latest news about Vectura Group

Chart Vectura Group

Company Profile